Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Mapping the evidence on the impact of mHealth interventions on patient-reported outcomes in patients with breast cancer: A systematic review

  • Frid, Santiago
  • Amat-Fernández, Clara
  • Fuentes-Expósito, María Ángeles
  • Muñoz-Mateu, Montserrat
  • Valachis, Antonis
  • Sisó Almirall, Antoni
  • Grau-Corral, Immaculada
Purpose: To comprehensively synthesize the existing evidence concerning mHealth interventions for patients with breast cancer (BC). Design: On July 30, 2023, we searched PubMed, PsycINFO, and Google Scholar for articles using the following inclusion criteria: evaluation of mHealth interventions in patients with cancer, at least 30 participants with BC, randomized control trials or prospective pre-post studies, determinants of health (patient-reported outcomes [PROs] and quality of life [QoL]) as primary outcomes, interventions lasting at least 8 weeks, publication after January 2015. Publications were excluded if they evaluated telehealth or used web-based software for desktop devices only. The quality of the included studies was analyzed with the Cochrane Collaboration Risk of Bias Tool and the Methodological Index for Non-Randomized Studies. Results: We included 30 studies (20 focused on BC), encompassing 5,691 patients with cancer (median 113, IQR, 135.5). Among these, 3,606 had BC (median 99, IQR, 75). All studies contained multiple interventions, including physical activity, tailored information for self-management of the disease, and symptom tracker. Interventions showed better results on self-efficacy (3/3), QoL (10/14), and physical activity (5/7). Lifestyle programs (3/3), expert consulting (4/4), and tailored information (10/11) yielded the best results. Apps with interactive support had a higher rate of positive findings, while interventions targeted to survivors showed worse results. mHealth tools were not available to the public in most of the studies (17/30). Conclusion: mHealth interventions yielded heterogeneous results on different outcomes. Identifying lack of evidence on clinical scenarios (eg, patients undergoing systemic therapy other than chemotherapy) could aid in refining strategic planning for forthcoming research endeavors within this field., This research work was carried out as part of the EU-funded Research and Innovation Action, Artificial intelligence Supporting CAncer Patients across Europe (ASCAPE; Project ID: 875351), [H2020-SC1-DTH-2019] SC1-DTH-01-2019, Big data and artificial intelligence for monitoring health status and quality of life after the cancer treatment.
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Estudio, informe, memoria (Report)

Cancer Survivorship and AI for Well-being White Paper: A European research projects collaborative perspective

  • Callejas Carrión, Zoraida|||0000-0001-8891-5237
  • Flynn, Tom
The Cancer Survivorship - AI for Well-being cluster (#CS_AIW) has brought together 11 EU-funded projects working in artificial intelligence (AI) for healthcare and well-being with the aim of transcending the individual project experiences and stop working in silos. The White Paper presents the #CS_AIW initiative and our collective shared vision, providing an overview of the participating projects and it reports on the achievements and lessons learned from our collaboration, including both the benefits obtained and the difficulties addressed. The experience with #CS_AIW to date has proven that collaboration within the cluster has been extremely beneficial and useful to foster an ethos of cross-fertilization engagement, share best practices, boost cross-sector collaboration, increase the participation of end user communities, and reach a wider audience. The activities organized, which encompass meetings, roundtable discussions, podcasts, a better practices guide, a common data space and the white paper itself, have proven to be an inherited valued initiative to generate, activate and communicate knowledge and innovation in the areas of mental health, well-being, cancer recovery, patient support and participatory research., The projects in #CS_AIW have received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no.: ASCAPE - Ref 875351 BD4QoL - Ref 875192 CAPABLE - Ref 875052 CLARIFY - Ref 860627 FAITH - Ref 875358 LIFECHAMPS - Ref 875329 MENHIR - Ref 823907 ONCORELIEF - Ref 875392 PERSIST - Ref 875406 QUALITOP - Ref 875171 REBECCA - Ref 65231
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Lessons Learned From European Health Data Projects With Cancer Use Cases: Implementation of Health Standards and Internet of Things Semantic Interoperability

  • Gyrard, Amelie
  • Abedian, Somayeh
  • Gribbon, Philip
  • Manias, George
  • van Nuland, Rick
  • Zatloukal, Kurt
  • Nicolae, Irina Emilia
  • Danciu, Gabriel
  • Nechifor, Septimiu
  • Marti-Bonmati, Luis
  • Mallol, Pedro
  • Dalmiani, Stefano
  • Autexier, Serge
  • Jendrossek, Mario
  • Avramidis, Ioannis
  • Blanquer Espert, Ignacio|||0000-0003-1692-8922
[EN] The adoption of the European Health Data Space (EHDS) regulation has made integrating health data critical for both primary and secondary applications. Primary use cases include patient diagnosis, prognosis, and treatment, while secondary applications support research, innovation, and regulatory decision-making. Additionally, leveraging large datasets improves training quality for artificial intelligence (AI) models, particularly in cancer prevention, prediction, and treatment personalization. The European related to fragmentation and the lack of standardization in metadata, data storage, access, and processing. This paper examines interoperability standards used in six EU-funded cancer-related projects: IDERHA (Integration of Heterogeneous Data and ASCAPE (Artificial Intelligence Supporting Cancer Patients Across Europe), iHelp, BigPicture, and the HealthData@EU pilot. These initiatives aim to enhance the analysis of heterogeneous health data while aligning with EHDS implementation, specifically for the EHDS for the secondary use of data (EHDS2). Between October 2023 and July 2024, we organized meetings and workshops among these projects to assess how they adopt health standards and apply Internet of Things (IoT) semantic interoperability. The discussions focused on interoperability standards for health data, knowledge graphs, the data quality framework, patient-generated health data, AI reasoning, federated approaches, security, and privacy. Based on our findings, we developed a template for designing the EHDS2 interoperability framework in alignment with the new European Interoperability Framework (EIF) and EHDS governance standards. This template maps EHDS2-recommended standards to the EIF model and principles, linking the proposed EHDS2 data quality framework to relevant International Organization for Standardization (ISO) standards. Using this template, we analyzed and compared how the recommended EHDS2 standards were implemented across the studied projects. During workshops, project teams shared insights on overcoming interoperability challenges and their innovative approaches to bridging gaps in standardization. With support from HSbooster.eu, we facilitated collaboration among these projects to exchange knowledge on standards, legal implementation, project sustainability, and harmonization with EHDS2. The findings from this work, including the created template and lessons learned, will be compiled into an interactive toolkit for the EHDS2 interoperability framework. This toolkit will help existing and future projects align with EHDS2 technical and legal requirements, serving as a foundation for a common EHDS2 interoperability framework. Additionally, standardization efforts include participation in the development of ISO/IEC 21823-3:2021-Semantic Interoperability for IoT Systems. Since no ISO standard currently exists for digital pathology and AI-based image analysis for medical diagnostics, the BigPicture project is contributing to ISO/PWI 24051-2, which focuses on digital pathology and AI-based, whole-slide image analysis. Integrating these efforts with ongoing ISO initiatives can enhance global standardization and facilitate widespread adoption across health care systems., AG declares funding from HSBOOSTER 101058391, StandICT.eu 2026 101091933. The IDERHA (Integration of Heterogeneous Data and Evidence Towards Regulatory and Health Technology Assessments Acceptance) project is supported by the Innovative Health Initiative (IHI) Joint Undertaking (JU) under grant agreement 101112135. The JU receives support from the European Union's Horizon Europe research and innovation program and life science industries represented by COCIR, EFPIA/Vaccines Europe, EuropaBio, and MedTech Europe. The BigPicture project has received funding from the Innovative Medicines Initiative 2 JU under grant agreement 945358. This JU receives support from the European Union's Horizon 2020 research and innovation program and EFPIA. The iHelp project received funding from the European Union's Horizon 2020 research and innovation program under grant agreement 101017441. The ASCAPE (Artificial Intelligence Supporting Cancer Patients Across Europe) project received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 875351. The EUCAIM (European Cancer Imaging Initiative) project is cofunded by the European Union under grant agreement 101100633. The HealthData@EU pilot is cofunded by the European Union.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Mapping the evidence on the impact of mHealth interventions on patient-reported outcomes in patients with breast cancer: A systematic review

  • Frid, Santiago
  • Amat-Fernández, Clara
  • Fuentes-Expósito, María Ángeles
  • Muñoz-Mateu, Montserrat
  • Valachis, Antonis
  • Sisó-Almirall, Antoni
  • Grau-Corral, Immaculada
Purpose: To comprehensively synthesize the existing evidence concerning mHealth interventions for patients with breast cancer (BC). Design: On July 30, 2023, we searched PubMed, PsycINFO, and Google Scholar for articles using the following inclusion criteria: evaluation of mHealth interventions in patients with cancer, at least 30 participants with BC, randomized control trials or prospective pre-post studies, determinants of health (patient-reported outcomes [PROs] and quality of life [QoL]) as primary outcomes, interventions lasting at least 8 weeks, publication after January 2015. Publications were excluded if they evaluated telehealth or used web-based software for desktop devices only. The quality of the included studies was analyzed with the Cochrane Collaboration Risk of Bias Tool and the Methodological Index for Non-Randomized Studies. Results: We included 30 studies (20 focused on BC), encompassing 5,691 patients with cancer (median 113, IQR, 135.5). Among these, 3,606 had BC (median 99, IQR, 75). All studies contained multiple interventions, including physical activity, tailored information for self-management of the disease, and symptom tracker. Interventions showed better results on self-efficacy (3/3), QoL (10/14), and physical activity (5/7). Lifestyle programs (3/3), expert consulting (4/4), and tailored information (10/11) yielded the best results. Apps with interactive support had a higher rate of positive findings, while interventions targeted to survivors showed worse results. mHealth tools were not available to the public in most of the studies (17/30). Conclusion: mHealth interventions yielded heterogeneous results on different outcomes. Identifying lack of evidence on clinical scenarios (eg, patients undergoing systemic therapy other than chemotherapy) could aid in refining strategic planning for forthcoming research endeavors within this field., This research work was carried out as part of the EU-funded Research and Innovation Action, Artificial intelligence Supporting CAncer Patients across Europe (ASCAPE; Project ID: 875351), [H2020-SC1-DTH-2019] SC1-DTH-01-2019, Big data and artificial intelligence for monitoring health status and quality of life after the cancer treatment.